GSTK1 and neoplasm: The subcutaneous tumor xenograft experiment in BALB/c-Nude mice demonstrated that GSTK1 overexpression resulted in a significant reduction in tumor size and weight compared to the control (pCDH) group, whereas GSTK1 knockdown led to increased tumor volume and weight relative to the normal control (NC) group (Fig. 2I, R).